Bank of New York Mellon’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $967K | Buy |
+150,837
| New | +$967K | ﹤0.01% | 3127 |
|
|
2024
Q4 | – | Sell |
-23,679
| Closed | -$76.7K | – | 4096 |
|
|
2024
Q3 | $76.7K | Buy |
+23,679
| New | +$76.7K | ﹤0.01% | 4016 |
|
|
2024
Q2 | – | Sell |
-198,029
| Closed | -$562K | – | 4119 |
|
|
2024
Q1 | $562K | Buy |
198,029
+7,029
| +4% | +$20K | ﹤0.01% | 3444 |
|
|
2023
Q4 | $2.81M | Buy |
191,000
+27,405
| +17% | +$403K | ﹤0.01% | 2651 |
|
|
2023
Q3 | $3M | Sell |
163,595
-286
| -0.2% | -$5.24K | ﹤0.01% | 2577 |
|
|
2023
Q2 | $3.53M | Sell |
163,881
-40,775
| -20% | -$880K | ﹤0.01% | 2509 |
|
|
2023
Q1 | $6M | Sell |
204,656
-5,483
| -3% | -$161K | ﹤0.01% | 2200 |
|
|
2022
Q4 | $7.76M | Buy |
210,139
+93,195
| +80% | +$3.44M | ﹤0.01% | 2075 |
|
|
2022
Q3 | $3.29M | Buy |
116,944
+87,923
| +303% | +$2.48M | ﹤0.01% | 2529 |
|
|
2022
Q2 | $558K | Buy |
29,021
+2,570
| +10% | +$49.4K | ﹤0.01% | 3523 |
|
|
2022
Q1 | $340K | Buy |
+26,451
| New | +$340K | ﹤0.01% | 3940 |
|